These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31066130)

  • 21. Evaluation of Clinical and Immunological Alterations Associated with ICF Syndrome.
    Bilgic Eltan S; Nain E; Catak MC; Ezen E; Sefer AP; Karimi N; Kiykim A; Kolukisa B; Baser D; Bulutoglu A; Kasap N; Yorgun Altunbas M; Yalcin Gungoren E; Kendir Demirkol Y; Kutlug S; Hancioglu G; Dilek F; Yildiran A; Ozen A; Karakoc-Aydiner E; Erman B; Baris S
    J Clin Immunol; 2023 Dec; 44(1):26. PubMed ID: 38129713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of ZBTB24 hampers the G0/1- to S-phase cell-cycle transition via upregulating the expression of IRF-4 in human B cells.
    Liang J; Yan R; Chen G; Feng J; Wu WW; Ren W; Zhu C; Zhao Y; Gao XM; Wang J
    Genes Immun; 2016 Jul; 17(5):276-82. PubMed ID: 27098601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three Types of Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome Identified by Whole-Exome Sequencing in Saudi Hypogammaglobulinemia Patients: Clinical, Molecular, and Cytogenetic Features.
    Alghamdi HA; Tashkandi SA; Alidrissi EM; Aledielah RD; AlSaidi KA; Alharbi ES; Habazi MK; Alzahrani MS
    J Clin Immunol; 2018 Nov; 38(8):847-853. PubMed ID: 30511102
    [No Abstract]   [Full Text] [Related]  

  • 24. Chromatin remodeling in replication-uncoupled maintenance DNA methylation and chromosome stability: Insights from ICF syndrome studies.
    Unoki M
    Genes Cells; 2021 Jun; 26(6):349-359. PubMed ID: 33960584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a mouse model of ICF syndrome reveals enhanced CD19 activation in inducing hypogammaglobulinemia.
    Ying Z; Hardikar S; Plummer JB; Hamidi T; Liu B; Chen Y; Shen J; Mu Y; McBride KM; Chen T
    bioRxiv; 2023 Mar; ():. PubMed ID: 36945532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive Immunodeficiency with Gradual Depletion of B and CD4⁺ T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2).
    Sogkas G; Dubrowinskaja N; Bergmann AK; Lentes J; Ripperger T; Fedchenko M; Ernst D; Jablonka A; Geffers R; Baumann U; Schmidt RE; Atschekzei F
    Diseases; 2019 Apr; 7(2):. PubMed ID: 30987377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gene mutations and subtelomeric DNA methylation in immunodeficiency, centromeric instability and facial anomalies syndrome.
    Hu H; Chen C; Shi S; Li B; Duan S
    Autoimmunity; 2019; 52(5-6):192-198. PubMed ID: 31476899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic, Cellular and Clinical Features of ICF Syndrome: a French National Survey.
    Sterlin D; Velasco G; Moshous D; Touzot F; Mahlaoui N; Fischer A; Suarez F; Francastel C; Picard C
    J Clin Immunol; 2016 Feb; 36(2):149-59. PubMed ID: 26851945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
    Langerud J; Jarhelle E; Van Ghelue M; Ariansen SL; Iversen N
    Hum Genomics; 2018 Nov; 12(1):51. PubMed ID: 30458859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.
    Velasco G; Grillo G; Touleimat N; Ferry L; Ivkovic I; Ribierre F; Deleuze JF; Chantalat S; Picard C; Francastel C
    Hum Mol Genet; 2018 Jul; 27(14):2409-2424. PubMed ID: 29659838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ZBTB24-CDCA7 axis regulates HELLS enrichment at centromeric satellite repeats to facilitate DNA methylation.
    Hardikar S; Ying Z; Zeng Y; Zhao H; Liu B; Veland N; McBride K; Cheng X; Chen T
    Protein Cell; 2020 Mar; 11(3):214-218. PubMed ID: 31970665
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease.
    Conrad MA; Dawany N; Sullivan KE; Devoto M; Kelsen JR
    Inflamm Bowel Dis; 2017 Dec; 23(12):2252-2255. PubMed ID: 29023266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Value of Chromosome Analysis to Interrogate Variants in DNMT3B Causing Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome Type I (ICF1).
    Kellner ES; Rathbun PA; Marshall GS; Tolusso LK; Smolarek TA; Sun M; Chandra S; Bleesing J; Marsh RA
    J Clin Immunol; 2019 Nov; 39(8):857-859. PubMed ID: 31686314
    [No Abstract]   [Full Text] [Related]  

  • 34. A high-throughput functional complementation assay for classification of BRCA1 missense variants.
    Bouwman P; van der Gulden H; van der Heijden I; Drost R; Klijn CN; Prasetyanti P; Pieterse M; Wientjens E; Seibler J; Hogervorst FB; Jonkers J
    Cancer Discov; 2013 Oct; 3(10):1142-55. PubMed ID: 23867111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.
    Unoki M; Funabiki H; Velasco G; Francastel C; Sasaki H
    J Clin Invest; 2019 Jan; 129(1):78-92. PubMed ID: 30307408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Mutation in a Critical Region for the Methyl Donor Binding in DNMT3B Causes Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome (ICF).
    Rechavi E; Lev A; Eyal E; Barel O; Kol N; Barhom SF; Pode-Shakked B; Anikster Y; Somech R; Simon AJ
    J Clin Immunol; 2016 Nov; 36(8):801-809. PubMed ID: 27734333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General population ZBTB18 missense variants influence DNA binding and transcriptional regulation.
    Hemming IA; Blake S; Agostino M; Heng JI
    Hum Mutat; 2020 Sep; 41(9):1629-1644. PubMed ID: 32598555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction.
    Caleca L; Catucci I; Figlioli G; De Cecco L; Pesaran T; Ward M; Volorio S; Falanga A; Marchetti M; Iascone M; Tondini C; Zambelli A; Azzollini J; Manoukian S; Radice P; Peterlongo P
    Front Oncol; 2018; 8():480. PubMed ID: 30410870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information.
    Osorio A; Milne RL; Honrado E; Barroso A; Diez O; Salazar R; de la Hoya M; Vega A; Benítez J
    Hum Mutat; 2007 May; 28(5):477-85. PubMed ID: 17279547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZEB2 zinc-finger missense mutations lead to hypomorphic alleles and a mild Mowat-Wilson syndrome.
    Ghoumid J; Drevillon L; Alavi-Naini SM; Bondurand N; Rio M; Briand-Suleau A; Nasser M; Goodwin L; Raymond P; Yanicostas C; Goossens M; Lyonnet S; Mowat D; Amiel J; Soussi-Yanicostas N; Giurgea I
    Hum Mol Genet; 2013 Jul; 22(13):2652-61. PubMed ID: 23466526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.